These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 17589614)
1. Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents. de Abreu LM; Meireles GC; Sumita MK; Forte AA; Aliaga Jdel C; Hayashi J Arq Bras Cardiol; 2007 May; 88(5):e111-4. PubMed ID: 17589614 [TBL] [Abstract][Full Text] [Related]
2. Proximal left anterior descending coronary artery revascularization with drug-eluting stents. Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW; J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247 [TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2. Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW; Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715 [TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent. Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247 [TBL] [Abstract][Full Text] [Related]
6. Very late thrombosis of paclitaxel-eluting stent. Aytekin V; Erdim R; Gormez S; Demiroglu C Cardiovasc Revasc Med; 2008; 9(4):275-7. PubMed ID: 18928954 [TBL] [Abstract][Full Text] [Related]
7. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731 [TBL] [Abstract][Full Text] [Related]
8. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555 [TBL] [Abstract][Full Text] [Related]
9. Retrograde embolization after balloon angioplasty in a patient with late stent subthrombosis in a paclitaxel-eluting stent. De Wolf A; Basoglu A; Vranckx P; Benit E Acta Cardiol; 2008 Dec; 63(6):797-9. PubMed ID: 19157178 [TBL] [Abstract][Full Text] [Related]
10. Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions. Lee CW; Park DW; Seung KB; Kim PJ; Park HJ; Kim WJ; Lee JY; Kang SJ; Lee SH; Kim YH; Park SW; Park SJ Am J Cardiol; 2011 Apr; 107(7):990-4. PubMed ID: 21296317 [TBL] [Abstract][Full Text] [Related]
11. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis. Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053 [TBL] [Abstract][Full Text] [Related]
12. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. Abdel-Wahab M; Richardt G; Joachim Büttner H; Toelg R; Geist V; Meinertz T; Schofer J; King L; Neumann FJ; Khattab AA JACC Cardiovasc Interv; 2013 Jan; 6(1):10-9. PubMed ID: 23266232 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. Ali RM; Degenhardt R; Zambahari R; Tresukosol D; Ahmad WA; Kamar Hb; Kui-Hian S; Ong TK; bin Ismail O; bin Elis S; Udychalerm W; Ackermann H; Boxberger M; Unverdorben M EuroIntervention; 2011 May; 7 Suppl K():K83-92. PubMed ID: 22027736 [TBL] [Abstract][Full Text] [Related]
14. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE; JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463 [TBL] [Abstract][Full Text] [Related]
15. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial. Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial. Maeng M; Jensen LO; Galloe AM; Thayssen P; Christiansen EH; Hansen KN; Helqvist S; Botker HE; Lassen JF; Thuesen L Am J Cardiol; 2009 Feb; 103(3):345-9. PubMed ID: 19166687 [TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial. Chevalier B; Dimario C; Neumann FJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Coe J; Schwartz LB; Catheter Cardiovasc Interv; 2013 Dec; 82(7):1039-47. PubMed ID: 23592567 [TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial. Desch S; Schloma D; Möbius-Winkler S; Erbs S; Gielen S; Linke A; Yu J; Lauer B; Kleinertz K; Dänschel W; Schuler G; Thiele H JACC Cardiovasc Interv; 2011 Apr; 4(4):452-9. PubMed ID: 21511226 [TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. Chevalier B; Di Mario C; Neumann FJ; Ribichini F; Urban P; Popma JJ; Fitzgerald PJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Schwartz LB; JACC Cardiovasc Interv; 2008 Oct; 1(5):524-32. PubMed ID: 19463354 [TBL] [Abstract][Full Text] [Related]
20. Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis. Bil J; Gil RJ; Vassilev D; Rzezak J; Kulawik T; Pawlowski T J Interv Cardiol; 2014 Jun; 27(3):242-51. PubMed ID: 24708143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]